rs17002284

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001429.4(EP300):​c.94+7744A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.261 in 151,840 control chromosomes in the GnomAD database, including 6,368 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.26 ( 6368 hom., cov: 30)

Consequence

EP300
NM_001429.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.597

Publications

5 publications found
Variant links:
Genes affected
EP300 (HGNC:3373): (E1A binding protein p300) This gene encodes the adenovirus E1A-associated cellular p300 transcriptional co-activator protein. It functions as histone acetyltransferase that regulates transcription via chromatin remodeling and is important in the processes of cell proliferation and differentiation. It mediates cAMP-gene regulation by binding specifically to phosphorylated CREB protein. This gene has also been identified as a co-activator of HIF1A (hypoxia-inducible factor 1 alpha), and thus plays a role in the stimulation of hypoxia-induced genes such as VEGF. Defects in this gene are a cause of Rubinstein-Taybi syndrome and may also play a role in epithelial cancer. [provided by RefSeq, Jul 2008]
EP300 Gene-Disease associations (from GenCC):
  • Rubinstein-Taybi syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: Illumina
  • Rubinstein-Taybi syndrome due to EP300 haploinsufficiency
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P, Ambry Genetics
  • retinitis pigmentosa
    Inheritance: AD Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.524 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EP300NM_001429.4 linkc.94+7744A>G intron_variant Intron 1 of 30 ENST00000263253.9 NP_001420.2 Q09472Q7Z6C1
EP300NM_001362843.2 linkc.94+7744A>G intron_variant Intron 1 of 29 NP_001349772.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EP300ENST00000263253.9 linkc.94+7744A>G intron_variant Intron 1 of 30 1 NM_001429.4 ENSP00000263253.7 Q09472
EP300ENST00000715703.1 linkc.94+7744A>G intron_variant Intron 1 of 30 ENSP00000520505.1
EP300ENST00000674155.1 linkc.94+7744A>G intron_variant Intron 1 of 29 ENSP00000501078.1 A0A669KB12
EP300ENST00000703544.1 linkn.94+7744A>G intron_variant Intron 1 of 29 ENSP00000515365.1 A0A994J6T4

Frequencies

GnomAD3 genomes
AF:
0.261
AC:
39656
AN:
151722
Hom.:
6376
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.0706
Gnomad AMI
AF:
0.299
Gnomad AMR
AF:
0.285
Gnomad ASJ
AF:
0.302
Gnomad EAS
AF:
0.540
Gnomad SAS
AF:
0.310
Gnomad FIN
AF:
0.276
Gnomad MID
AF:
0.280
Gnomad NFE
AF:
0.341
Gnomad OTH
AF:
0.302
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.261
AC:
39634
AN:
151840
Hom.:
6368
Cov.:
30
AF XY:
0.261
AC XY:
19347
AN XY:
74198
show subpopulations
African (AFR)
AF:
0.0704
AC:
2916
AN:
41446
American (AMR)
AF:
0.285
AC:
4333
AN:
15218
Ashkenazi Jewish (ASJ)
AF:
0.302
AC:
1048
AN:
3470
East Asian (EAS)
AF:
0.541
AC:
2785
AN:
5152
South Asian (SAS)
AF:
0.309
AC:
1487
AN:
4814
European-Finnish (FIN)
AF:
0.276
AC:
2913
AN:
10536
Middle Eastern (MID)
AF:
0.271
AC:
79
AN:
292
European-Non Finnish (NFE)
AF:
0.341
AC:
23174
AN:
67910
Other (OTH)
AF:
0.300
AC:
629
AN:
2098
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1336
2672
4008
5344
6680
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
414
828
1242
1656
2070
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.269
Hom.:
804
Bravo
AF:
0.254
Asia WGS
AF:
0.412
AC:
1430
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
0.97
DANN
Benign
0.69
PhyloP100
-0.60
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17002284; hg19: chr22-41496846; API